UBE2C and breast carcinoma: Apart from ER+ and ER− breast cancers, we also compared the expression of UBE2S, UBE2C, and Numb in PR positive (PR+) and PR negative (PR−) breast cancers as well as in HER2 positive (HER2+) and HER2 negative (HER2−) breast cancers.